CNTGF — Crown LiquidationCo NV in liquidatie Share News
0.000.00%
Last trade - 00:00TechnologySpeculativeMicro Cap
- $3.48m
- $74.53m
- €48.54m
Centogene slides after co flags going concern doubts
Brief: Centogene Reports Third Quarter 2021 Financial Results
Brief: CENTOGENE Expands Partnership With Agios To Generate Novel Insights Into Rare Blood Diseases
Brief: Centogene Enrolls First Patient In Frontotemporal Dementia Clinical Study
Brief: Centogene Enrolls First Patient In Frontotemporal Dementia Clinical Study
Brief: Twist Bioscience And Centogene To Develop Advanced Sequencing Tools To Make Genetic Testing Rapidly Accessible For More Patients With Rare Diseases
Brief: Centogene Says Genetic Research Study Published In NEJM
Centogene NV gains as more COVID-19 testing lifts Q2 revenue
Brief: Centogene Appoints Patrice P. Denèfle As Chief Scientific Officer To Lead Its Data-Driven Approach To Reinvent Rare Disease Drug Discovery And Development
Brief: Centogene Announces Shareholders Approve All Resolutions At Annual General Meeting
Brief: Centogene Sets Mission To Enable Cure Of 100 Rare Diseases Within Next 10 Years
Brief: Centogene Sets Mission To Enable The Cure Of 100 Rare Diseases Within The Next 10 Years
Brief: Centogene Reports Q1 2021 Financial Results
Brief: Centogene Initiates EFRONT Study To Identify Patients With Genetic Forms Of Frontotemporal Dementia
Brief: Centogene Launches Centoxome Whole Exome Sequencing Solution
Brief: Centogene Announces The Nomination Of Rene Just As CFO
Brief: Centogene Extends Global Parkinson’s Disease Study
Brief: Centogene Reports Q4 And Full Year 2020 Financial Results
Brief: Centogene Extends Partnership With Takeda